Skip to main content
. 2023 Jun 29;7:e2300030. doi: 10.1200/PO.23.00030

FIG 1.

FIG 1.

rwPFS and OS among patients who received sotorasib for advanced KRAS G12C-mutant Non–Small Cell lung cancer. Kaplan-Meier curve of (A) rwPFS and (B) OS among evaluable patients. Tick marks indicate censored data. OS, overall survival; rwPFS, real-world progression-free survival.